Leaders in the field of neuroendocrine tumors offer insights in this moderated series. The healthcare professionals in this podcast are paid consultants for Ipsen. Each episode features insights on diagnosis, treatment for certain types of NETs, and more. This content is intended for US healthcare providers only. Find out more about a treatment option at TreatingNETs.com. Please view Ipsen's Privacy Policy and Terms of Use at www.ipsen.com/us.
Dr. Robert Ramirez, a member of the American Society of Clinical Oncology (ASCO), and NET nurse navigator Pam Ryan discuss the importance of the multi...
Dr. Robert Ramirez, a member of the American Society of Clinical Oncology (ASCO), and NET nurse navigator Pam Ryan discuss the importance of the multi...
Dr. Daneng Li, co-director of the neuroendocrine tumor program at City of Hope National Medical Center, offers his expertise and insight on diagnosis,...
Dr. Jonathan Strosberg, associate professor at Moffitt Cancer Center, discusses a hypothetical patient with symptomatic carcinoid midgut NET. Dr. Stro...
Dr. Daneng Li, co-director of the neuroendocrine tumor program at City of Hope National Medical Center, offers his expertise and insight on diagnosis,...
Dr. Jonathan Strosberg, associate professor at Moffitt Cancer Center, discusses a hypothetical patient with symptomatic carcinoid midgut NET. Dr. Stro...
Dr. Andrew Hendifar, medical oncology lead for the Gastrointestinal Disease Research Group at Cedars-Sinai Medical Center, discusses a hypothetical pa...
Dr. Andrew Hendifar, medical oncology lead for the Gastrointestinal Disease Research Group at Cedars-Sinai Medical Center, discusses a hypothetical pa...